Oesophageal Probe Evaluation in RF Ablation of Atrial Fibrillation
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.
Also called NCT03246594
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 200 participants
- Registry
-
NCT03246594
-
- Other papers using this trial's data
- Oesophageal Probe Evaluation in Radiofrequency Ablation of Atrial Fibrillation (OPERA): results from a prospective randomized trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Germany
- Registry status
- Completed
Technical summary
Registry record NCT03246594. Randomized; single masking; primary purpose treatment. Start 2017-07-03 (actual); primary completion 2019-04-25 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Oesophageal Probe Evaluation in RF Ablation of Atrial Fibrillation
- Acronym
- OPERA
- Condition
- Atrial Fibrillation
- Intervention (Device)
- Placement of oesophageal probe for temperature measurement
- Intervention (Device)
- Power limitation of RF generator
- Lead sponsor
- Heart Center Leipzig - University Hospital
Record details
- Record id
cardio:ct-nct03246594- Content hash
d37f5d70a7327d9645450ac57705ea4aca7c4fa969edcc887f809bf329a909eb